ArticleCureus2026
Outcomes of Mohs Micrographic Surgery Compared to Wide Local Excision for Malignant Melanoma and Melanoma In Situ.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mohs micrographic surgery (MMS), traditionally used for non-melanoma skin cancers, has been used for some cases of melanoma. Using the TriNetX (TriNetX, LLC, Cambridge, MA, USA) database, two analyses were performed. The first compared wide local excision (WLE) and MMS for the management of malignant melanoma (MM) of the face, scalp, and neck. The second analysis compared WLE and melanoma in situ (MIS) of the same anatomical areas. WLE was associated with a significantly higher incidence of secondary and unspecified malignant neoplasms of the lymph nodes of the head and neck and secondary malignant neoplasm of the bone, lung, and brain in the MM analysis. In the MIS analysis, WLE was found to have higher rates of secondary malignant neoplasms of the head and neck, bone, lung, and brain. The post-operative complication rates were similar between the MMS and WLE groups in both analyses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.